Abstract
In recent years there has been a growing body of evidence from laboratory and clinical studies that at least 2% of newborns have been exposed to an asphyxial insult during labor and delivery, which may affect their outcome. Despite all the progress achieved in obstetric and neonatal care, intrapartum fetal asphyxia is still a major cause of hypoxicischaemic brain injury in term newborns such the one caused by pre-eclampsia, a complication of pregnancy that can cause birth asphyxia at or near term, due to influence on uteroplacental circulation, resulting in brain damage. Up to now it has not been possible to assess fetal brain function directly while the membranes are intact. Several indirect methods are in clinical use such as cardiotocography, biophysical profile, amniotic fluid examination, Doppler sonography, hormone analysis, and ultrasound investigations of fetal growth and movements. During the last decade fetal magnetoencephalography (MEG) has been developed as a useful screening tool for detection of severely neurologically damaged fetuses due to its ability to record brain activity without direct contact with the head as well as to the transparency of magnetic signals in passing through extracerebral fetal layers and through the mothers abdomen. Few studies in the literature refer to neonatal MEG. This article provides an overview of the uses and limitations of fetal and neonatal MEG, especially in the detection of brain damage due to perinatal hypoxia.
Keywords: fetuses, neonates, perinatal hypoxia, magnetoencephalography
Current Pediatric Reviews
Title: Magnetoencephalography in Fetuses and Neonates: A Review
Volume: 1 Issue: 2
Author(s): Panagiotis Anastasiadis, Athanasia Kotini, Nikoleta Koutlaki, Axilleas N. Anastasiadis and Photios Anninos
Affiliation:
Keywords: fetuses, neonates, perinatal hypoxia, magnetoencephalography
Abstract: In recent years there has been a growing body of evidence from laboratory and clinical studies that at least 2% of newborns have been exposed to an asphyxial insult during labor and delivery, which may affect their outcome. Despite all the progress achieved in obstetric and neonatal care, intrapartum fetal asphyxia is still a major cause of hypoxicischaemic brain injury in term newborns such the one caused by pre-eclampsia, a complication of pregnancy that can cause birth asphyxia at or near term, due to influence on uteroplacental circulation, resulting in brain damage. Up to now it has not been possible to assess fetal brain function directly while the membranes are intact. Several indirect methods are in clinical use such as cardiotocography, biophysical profile, amniotic fluid examination, Doppler sonography, hormone analysis, and ultrasound investigations of fetal growth and movements. During the last decade fetal magnetoencephalography (MEG) has been developed as a useful screening tool for detection of severely neurologically damaged fetuses due to its ability to record brain activity without direct contact with the head as well as to the transparency of magnetic signals in passing through extracerebral fetal layers and through the mothers abdomen. Few studies in the literature refer to neonatal MEG. This article provides an overview of the uses and limitations of fetal and neonatal MEG, especially in the detection of brain damage due to perinatal hypoxia.
Export Options
About this article
Cite this article as:
Anastasiadis Panagiotis, Kotini Athanasia, Koutlaki Nikoleta, Anastasiadis N. Axilleas and Anninos Photios, Magnetoencephalography in Fetuses and Neonates: A Review, Current Pediatric Reviews 2005; 1 (2) . https://dx.doi.org/10.2174/1573396054065484
DOI https://dx.doi.org/10.2174/1573396054065484 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Highly Organized Nanostructures for Brain Drug Delivery - New Hope or Just a Fad?
CNS & Neurological Disorders - Drug Targets Tau Pathology and Future Therapeutics
Current Alzheimer Research Current Insights into the Role of HIF-1 in Cutaneous Wound Healing
Current Molecular Medicine From Brain Ischemia-Reperfusion Injury to Possible Sporadic Alzheimers Disease
Current Neurovascular Research Optimized Methods for In Vitro and In Vivo Anti-Inflammatory Assays and Its Applications in Herbal and Synthetic Drug Analysis
Mini-Reviews in Medicinal Chemistry The Role of CXCR3 in Neurological Diseases
Current Neuropharmacology Current Treatment Strategies for Multiple Sclerosis - Efficacy Versus Neurological Adverse Effects
Current Pharmaceutical Design Exosomes Harnessed as Nanocarriers for Cancer Therapy - Current Status and Potential for Future Clinical Applications
Current Molecular Medicine Recent Patents on Novel P2X7 Receptor Antagonists and their Potential for Reducing Central Nervous System Inflammation
Recent Patents on CNS Drug Discovery (Discontinued) Phytocompounds as Potential Agents to Treat Obesity-Cardiovascular Ailments
Cardiovascular & Hematological Agents in Medicinal Chemistry Nutritional Assessment in the Critically Ill Child
Current Pediatric Reviews Translocator Protein (TSPO) Role in Aging and Alzheimer’s Disease
Current Aging Science Dopamine Administration in Very Low Birth Weight Preterm Infants:Emerging Issues on Endocrine Effects
Current Pediatric Reviews Brain Drug Delivery Systems for the Stroke Intervention and Recovery
Current Pharmaceutical Design Molecular Mechanisms Regulating Matrix Metalloproteinases
Current Topics in Medicinal Chemistry Anti-Diabetic Effects of Isolated Lipids from Natural Sources through Modulation of Angiogenesis
Current Molecular Pharmacology Mechanism of Action of Flavonoids as Anti-inflammatory Agents: A Review
Inflammation & Allergy - Drug Targets (Discontinued) Aldose Reductase / Polyol Inhibitors for Diabetic Retinopathy
Current Pharmaceutical Biotechnology Editorial (Current and Emerging Pharmacological Therapies of Ischaemic Stroke)
CNS & Neurological Disorders - Drug Targets Parasite Prolyl Oligopeptidases and the Challenge of Designing Chemotherapeuticals for Chagas Disease, Leishmaniasis and African Trypanosomiasis
Current Medicinal Chemistry